Editors' ChoiceFOCIS HIGHLIGHTS A role for T helper cells in anti–CTLA-4 therapy Andrew H. LichtmanDepartment of Pathology, Brigham and Women's Hospital, Boston, MA 02115, USA. Email:alichtman{at}partners.org See allHide authors and affiliations Science Immunology 01 Sep 2017:Vol. 2, Issue 15, eaao6871DOI: 10.1126/sciimmunol.aao6871 Andrew H. Lichtman Department of Pathology, Brigham and Women's Hospital, Boston, MA 02115, USA. Email:Find this author on Google Scholar Find this author on PubMed Search for this author on this site For correspondence: alichtman@partners.org Article Info & Metrics eLetters Article Information vol. 2 no. 15 DOI: https://doi.org/10.1126/sciimmunol.aao6871 PubMed: 28864497 Published By: Science Immunology History: . Copyright & Usage: Copyright © 2017, American Association for the Advancement of Science Author Information Andrew H. LichtmanDepartment of Pathology, Brigham and Women's Hospital, Boston, MA 02115, USA. Email:alichtman{at}partners.org Altmetric Article usage Article lifetimeLast 6 monthsThis monthArticle usage: August 2017 to January 2021 AbstractFullPdf Aug 2017220 Sep 2017350516790 Oct 20177943960 Nov 20172091140 Dec 2017136730 Jan 2018122560 Feb 201883430 Mar 201885381 Apr 201869420 May 201854440 Jun 201859360 Jul 201826280 Aug 20180651 Sep 20180500 Oct 201801621 Nov 20180760 Dec 20180870 Jan 20195900 Feb 20197880 Mar 201911080 Apr 20190380 May 20192200 Jun 20192270 Jul 20191292 Aug 20191280 Sep 20192320 Oct 20191260 Nov 20192320 Dec 20191360 Jan 20201370 Feb 20200480 Mar 20201360 Apr 20201270 May 20201220 Jun 20201190 Jul 20201170 Aug 20200250 Sep 20207220 Oct 20201580 Nov 20201500 Dec 20203810 Jan 20211330 View Full Text
A role for T helper cells in anti–CTLA-4 therapy By Andrew H. Lichtman Science Immunology01 Sep 2017 Comparison of immune responses to CTLA4 and PD-1 blockade uncovers a role for helper T cells in anti–CTLA-4 therapy.
A role for T helper cells in anti–CTLA-4 therapy By Andrew H. Lichtman Science Immunology01 Sep 2017 Comparison of immune responses to CTLA4 and PD-1 blockade uncovers a role for helper T cells in anti–CTLA-4 therapy.